Geode Capital Management, LLC Arbutus Biopharma Corp Transaction History
Geode Capital Management, LLC
- $1.24 Trillion
- Q1 2025
A detailed history of Geode Capital Management, LLC transactions in Arbutus Biopharma Corp stock. As of the latest transaction made, Geode Capital Management, LLC holds 3,541,145 shares of ABUS stock, worth $11.1 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
3,541,145
Previous 3,482,136
1.69%
Holding current value
$11.1 Million
Previous $11.4 Million
8.54%
% of portfolio
0.0%
Previous 0.0%
Shares
30 transactions
Others Institutions Holding ABUS
# of Institutions
189Shares Held
111MCall Options Held
866KPut Options Held
608K-
Morgan Stanley New York, NY23.8MShares$74.7 Million0.01% of portfolio
-
Whitefort Capital Management, LP New York, NY13.3MShares$41.8 Million27.3% of portfolio
-
Black Rock Inc. New York, NY11.6MShares$36.3 Million0.0% of portfolio
-
Two Seas Capital LP Rye, NY9.47MShares$29.7 Million1.19% of portfolio
-
Vanguard Group Inc Valley Forge, PA8.95MShares$28.1 Million0.0% of portfolio
About Arbutus Biopharma Corp
- Ticker ABUS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 149,951,008
- Market Cap $471M
- Description
- Arbutus Biopharma Corporation, a biopharmaceutical company, develops novel therapeutics for chronic Hepatitis B virus (HBV) infection, SARS-CoV-2, and other coronaviruses in the United States. Its HBV product pipeline consists of AB-729, a proprietary subcutaneously delivered RNA interference product candidate, which in Phase Ia/Ib clinical tria...